"label","text","description","id","name","uuid:ID","instanceType"
"","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","Main objective","Objective_1","OBJ1","42d4401e-2ab7-4f84-8880-dfb160e7a18f","Objective"
"","To document the safety profile of the xanomeline TTS.","Safety","Objective_2","OBJ2","72ed4828-0c0c-43af-9adc-1f58a47b2cb7","Objective"
"","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","Behaviour","Objective_3","OBJ3","16079ca6-e6d2-4a3d-b698-33165c811a90","Objective"
